RegeneRx Biopharmaceuticals, Inc.
RGRX
$0.0002
$0.000.00%
OTC PK
| 03/31/2023 | 12/31/2022 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 0.00% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 0.00% | 0.00% | |||
| SG&A Expenses | -1.19% | 8.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.19% | 8.00% | |||
| Operating Income | 1.26% | -8.54% | |||
| Income Before Tax | 1.46% | -6.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.46% | -6.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.46% | -6.66% | |||
| EBIT | 1.26% | -8.54% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 1.47% | -6.66% | |||
| Normalized Basic EPS | 1.47% | -6.64% | |||
| EPS Diluted | -5.09% | 0.00% | |||
| Normalized Diluted EPS | 1.47% | -6.64% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||